User profiles for "author:Violante Di Donato"
Violante Di Donato MD PhDDepartment of Obstetrics and Gynecology, “Sapienza” University of Rome Verified email at uniroma1.it Cited by 5170 |
[HTML][HTML] Role of genomic and molecular biology in the modulation of the treatment of endometrial cancer: narrative review and perspectives
I Cuccu, O D'Oria, L Sgamba, E De Angelis… - Healthcare, 2023 - mdpi.com
Endometrial cancer (EC) is one of the most common gynecological malignancies in Western
countries. Traditionally, loco-reginal dissemination and histological characteristics are the …
countries. Traditionally, loco-reginal dissemination and histological characteristics are the …
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
C Marchetti, I Palaia, M Giorgini… - OncoTargets and …, 2014 - Taylor & Francis
Ovarian cancer is the most common cause of gynecological cancer-related mortality, with
the majority of women presenting with advanced disease; although chemotherapeutic …
the majority of women presenting with advanced disease; although chemotherapeutic …
[HTML][HTML] Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis
L Muzii, C Di Tucci, M Di Feliciantonio, G Galati… - Fertility and sterility, 2018 - Elsevier
Objective To evaluate if the presence of endometriomas impacts on the ovarian reserve as
evaluated with antimüllerian hormone (AMH). Design Systematic review and meta-analysis …
evaluated with antimüllerian hormone (AMH). Design Systematic review and meta-analysis …
[HTML][HTML] Novel insights into molecular mechanisms of endometrial diseases
T Golia D'Augè, I Cuccu, G Santangelo, L Muzii… - Biomolecules, 2023 - mdpi.com
Endometrial diseases are the most common gynecological pathologies in Western
Countries. Among these, endometrial cancer (EC) is the most common gynecological …
Countries. Among these, endometrial cancer (EC) is the most common gynecological …
[HTML][HTML] Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization
A Giannini, V Di Donato, F Sopracordevole, A Ciavattini… - Vaccines, 2023 - mdpi.com
The objective of this work is to assess the 5-year outcomes of patients undergoing
conization for high-grade cervical lesions that simultaneously present as risk factors in the …
conization for high-grade cervical lesions that simultaneously present as risk factors in the …
[HTML][HTML] Novel insights into molecular mechanisms of endometrial diseases
TG D'Augè, I Cuccu, G Santangelo, L Muzii… - …, 2023 - ncbi.nlm.nih.gov
Endometrial diseases are the most common gynecological pathologies in Western
Countries. Among these, endometrial cancer (EC) is the most common gynecological …
Countries. Among these, endometrial cancer (EC) is the most common gynecological …
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis
L Muzii, C Di Tucci, C Achilli, V Di Donato… - American journal of …, 2016 - Elsevier
In the lack of evidence consistently supporting the use of continuous vs cyclic oral
contraceptives after surgery for endometriosis, we conducted a systematic review and …
contraceptives after surgery for endometriosis, we conducted a systematic review and …
Uterine serous carcinoma
G Bogani, I Ray-Coquard, N Concin, NYL Ngoi… - Gynecologic …, 2021 - Elsevier
Serous endometrial cancer represents a relative rare entity accounting for about 10% of all
diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related …
diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related …
[HTML][HTML] Immunotherapy in endometrial cancer: new scenarios on the horizon
C Di Tucci, C Capone, G Galati, V Iacobelli… - Journal of …, 2019 - ncbi.nlm.nih.gov
This extensive review summarizes clinical evidence on immunotherapy and targeted
therapy currently available for endometrial cancer (EC) and reports the results of the clinical …
therapy currently available for endometrial cancer (EC) and reports the results of the clinical …
[HTML][HTML] Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis
Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …